A Comprehensive Guide to Leprosy Treatment and Rehabilitation

Leprosy – also known as Hansen’s disease – is one of the oldest known human infections, yet it remains a public health concern in several parts of the world. According to the WHO, approximately 200,000 new cases are still reported globally each year, with Brazil, India, and Indonesia continuing to account for the largest share. What makes leprosy particularly complex is that the disease does not just affect the skin – it attacks peripheral nerves, eyes, and the upper respiratory tract, and if left untreated, it leads to permanent disability and deep social stigma. The good news is that leprosy is entirely curable, and with the right combination of early diagnosis, drug therapy, and rehabilitation, individuals affected by it can return to full, independent lives. This guide walks through the entire continuum of care – from spotting the first signs to restoring function and independence.

The critical role of early diagnosis 🔗

The single most important factor in preventing disability from leprosy is catching it early. The WHO confirms that leprosy is diagnosed clinically and is based on at least one of three cardinal signs: a definite loss of sensation in a pale or reddish skin patch; a thickened or enlarged peripheral nerve with loss of sensation or muscle weakness; or the microscopic detection of bacilli in a slit-skin smear. These signs – particularly patches of skin with reduced or absent sensation and numbness in the hands or feet – are the body’s early warning system. Recognising them promptly is everything.

Once symptoms appear, delayed action has serious consequences. A clinical study published in the Journal of Contemporary Clinical Practice found that 48% of newly diagnosed leprosy patients already had Grade 2 disability – meaning visible deformities – at the time of presentation, underscoring how common diagnostic delays are. MDT cannot reverse existing nerve damage; it can only stop further progression. This is why identifying the disease before irreversible nerve damage sets in is so crucial. Early detection also has a social benefit – the patient stops transmitting the disease as soon as treatment begins, breaking the chain of infection.

Multi-drug therapy (MDT): the cornerstone of leprosy treatment 🔗

Leprosy is curable, and the treatment that made this possible is Multi-Drug Therapy (MDT). The WHO has recommended MDT since 1982, and it has been the global standard ever since. The regimen combines three drugs – rifampicin, dapsone, and clofazimine – which work together to kill the causative bacteria, Mycobacterium leprae, while preventing drug resistance. Using a single drug (monotherapy) is specifically avoided because it leads to resistance.

Treatment duration depends on the type of leprosy. The WHO recommends a 6-month course for paucibacillary (PB) leprosy, where there are 1-5 skin lesions, and a 12-month course for multibacillary (MB) leprosy, involving more than five lesions or nerve damage. More than 16 million leprosy patients have been successfully treated with MDT worldwide, and the drugs are provided free of cost to all endemic countries through a Novartis donation facilitated by the WHO. The impact has been transformative – the introduction of MDT significantly reduced global leprosy prevalence from millions of cases in the 1980s to under 200,000 new annual cases today. However, MDT alone is not always sufficient – rehabilitation is an equally essential part of recovery for those who already have nerve damage or disability.

Physical therapy and physiotherapy for recovery 🔗

For many individuals, the damage caused by leprosy does not end when drug treatment is completed. Peripheral nerve damage can leave people with weakened muscles, reduced joint movement, contractures, and loss of sensation – all of which require dedicated physical rehabilitation. Physiotherapists working in leprosy care classify disability degrees and monitor neural function, using this information to design targeted treatment plans.

The core approaches in physiotherapy for leprosy include muscle strengthening and stretching exercises, passive and active joint mobilisation, proprioceptive neuromuscular facilitation (PNF), neural mobilisation techniques, and electrotherapy modalities such as TENS to manage pain. Before surgery, physiotherapy focuses on maintaining joint flexibility through active and isometric exercises and reducing stiffness. After surgical procedures, it shifts to restoring range of motion through hydrotherapy, manual stretching, gentle mobilisation, and facilitated stretching techniques. The overall goals of physiotherapy are to increase joint range of motion, build muscle strength, prevent contractures and deformities, preserve functional movement, and prepare patients for daily living – both before and after any surgical intervention.

The role of occupational therapy 🔗

Where physiotherapy focuses on restoring physical function, occupational therapy (OT) focuses on restoring the ability to live and work independently. Occupational therapists in leprosy care provide assistive devices such as padded utensils, grip aids, and adaptive equipment to compensate for impairments and support participation in activities of daily living (ADL), work, and leisure. The goal is to enable meaningful participation in everyday life – not just physical recovery.

Occupational therapy services in leprosy rehabilitation include a functional assessment of hand function and ADL performance, individual or group therapy sessions, fabrication of assistive aids and protective devices, ergonomic modifications for work tools, injury avoidance education for patients with anaesthetic (insensate) limbs, and recommendations for home accessibility adaptations. Splinting is a key OT intervention – splints are used to prevent deformities such as claw hand by holding joints in a corrective position. Gait training with adaptive devices helps individuals with foot drop or balance issues regain safe, independent mobility. A research study published in PLOS Neglected Tropical Diseases found that assistive technology meaningfully improved the autonomy and self-care capacity of leprosy patients, highlighting the power of OT interventions to restore both function and dignity.

Surgical interventions for deformities 🔗

When nerve damage in leprosy results in significant deformities or motor paralysis, surgery becomes a critical part of the rehabilitation pathway. According to the Klarity Health Library, the primary goals of leprosy surgery are functional restoration, prevention of complications such as ulcers and further contractures, cosmetic improvement – particularly for facial deformities – and psychosocial rehabilitation through regained mobility and appearance.

Tendon transfer for claw hand and foot drop 🔗

Claw hand – caused by ulnar nerve damage – is one of the most common deformities in leprosy. Surgical repair involves tendon transfers, where a functioning tendon is rerouted to restore the ability to grip, extend fingers, and oppose the thumb. For foot drop, caused by damage to the common peroneal nerve, the posterior tibial tendon transfer is the most frequently used procedure – it moves an intact tendon to help the patient lift the foot when walking, reducing falls and foot ulceration. Surgery for foot drop is generally considered after 12 months if there is no spontaneous recovery, since 50% of cases can recover on their own within the first year.

Nerve decompression 🔗

When nerves become swollen or compressed due to leprosy-related inflammation, surgical nerve decompression can relieve pressure before permanent damage occurs. A study of peripheral nerve decompression in leprosy reported that neuritic pain resolved in all cases of ulnar, median, and posterior tibial nerve surgery, with motor recovery achieved in 89% of ulnar nerve cases and 70% of median nerve cases – outcomes that would not have been possible without surgical intervention. Common sites for decompression include the ulnar nerve at the elbow, the median nerve at the wrist, and the posterior tibial nerve at the ankle.

Eye surgery and other procedures 🔗

Facial nerve involvement in leprosy can cause lagophthalmos – the inability to fully close the eyelids – which exposes the eyes to injury, dryness, and infection. Surgical options include tarsorrhaphy (partially stitching the eyelids together) or implanting a small gold or platinum weight in the upper eyelid to enable gravity-assisted closure. Reconstructive surgery for leprosy also includes skin grafts to cover wounds and ulcerated areas, nasal reconstruction for collapsed nasal bridges, and procedures to release thumb web contractures.

Protection from injury and self-care 🔗

One of the most underappreciated aspects of leprosy rehabilitation is protecting insensitive areas from injury. When a person cannot feel pain in their hands or feet, they are at constant risk of burns, cuts, pressure injuries, and ulcers – often without even realising they have been hurt. Hands and feet with loss of protective sensation are particularly prone to burns and ulceration, and for every injury, the underlying cause must be identified and addressed to prevent recurrence.

Comprehensive self-care training is essential for every leprosy patient with nerve damage. This includes daily inspection of anaesthetic limbs for cuts, blisters, or swelling; the use of protective footwear with cushioned insoles to prevent plantar ulcers; regular moisturising to prevent skin cracking; and eye care routines for those with lagophthalmos. A structured wound and ulcer management approach widely used in leprosy programmes is the ISSOD protocol – Inspection, Soaking, Scraping, Oiling, and Dressing. This systematic daily routine helps clean and manage plantar ulcers, promote healing, and prevent secondary infections. Self-care education is considered an integral part of rehabilitation – patients are trained intensively in protective behaviours so they can manage their own care at home and reduce their dependence on clinical visits.

Assistive devices and technology for independence 🔗

Assistive devices form the practical bridge between medical treatment and real-world independence. For individuals affected by leprosy, these devices compensate for physical limitations and enable participation in daily activities, work, and social life. They fall into several distinct categories, each addressing a specific type of functional need.

Orthotic devices – such as braces, splints, and custom insoles – support weakened joints, prevent deformity progression, and enable safer movement. Prosthetic devices are used in cases where amputation has been necessary due to severe infection or tissue loss. Mobility aids such as crutches, walking sticks, and specialised footwear support individuals with foot drop, instability, or plantar ulcers. ADL (activities of daily living) kits contain adapted tools – modified cutlery, grip aids, dressing aids – that allow individuals with hand impairments to eat, dress, and manage personal hygiene independently.

Research on the use of assistive technology in leprosy rehabilitation found that adapted devices reduced functional limitations in daily living activities and had a meaningful positive impact on patients’ sense of autonomy, self-care, and social inclusion. Occupational therapists recommend environmental adaptations as well – modifications to homes and workplaces that ensure accessibility and safety. The overarching aim is not just physical function, but a full return to the roles that matter most to each person: as a parent, a worker, a community member.

The WHO’s Global Leprosy Strategy 2021-2030 envisions “zero leprosy” – zero infection, zero disability, zero stigma, and zero discrimination. Achieving that vision depends not just on drugs and surgery, but on the full spectrum of care described here: early diagnosis, MDT, physiotherapy, occupational therapy, surgical correction, self-care training, and assistive technology working in concert. Each component is indispensable; together, they offer individuals affected by leprosy a genuine path back to health, dignity, and independence.

What do you think? Given that so many patients still present with advanced disability at the time of diagnosis, what do you think are the biggest barriers to early leprosy detection in high-burden communities – and how might health education address them? And with rehabilitation requiring such a multidisciplinary team, how should healthcare systems in resource-limited settings prioritise these services to ensure no one is left behind?

References

1. https://www.who.int/news-room/fact-sheets/detail/leprosy
2. https://www.who.int/health-topics/leprosy
3. https://jccpractice.com/article/a-study-of-who-disabilities-in-leprosy-patients-before-and-after-multi-drug-therapy-mdt–1040/
4. https://www.who.int/teams/control-of-neglected-tropical-diseases/leprosy/treatment
5. https://www.who.int/activities/facilitating-the-provision-of-medicines-for-leprosy
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC11346855/
7. https://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822019000300014
8. https://www.physio-pedia.com/Leprosy
9. https://leprosyhealth.org/occupational-therapy-ot/
10. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004644
11. https://my.klarity.health/surgical-management-of-leprosy-related-disabilities-and-deformities/
12. https://emedicine.medscape.com/article/220455-treatment
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC6664842/
14. https://pubmed.ncbi.nlm.nih.gov/19823660/
15. https://www.sciencedirect.com/science/article/abs/pii/S0738081X15001947